Smart Footwear Pushing into mHealth to Provide Home and Remote Patient Care

ABI Research Forecasts the Now Nascent mHealth Markets Will See Growth Upwards of 85% by 2021
15 Nov 2016

As the now nascent smart footwear market begins to develop, ABI Research forecasts tremendous growth in its future, driven by mHealth applications. Overall, unit shipments will rise to more than 6 million in 2021 from just 300,000 in 2016, an 82% CAGR. By supporting sensors within shoes or smart socks, home monitoring and remote patient management applications can track a host of valuable parameters with minimal disruption to those being monitored.

“The growing elderly population is driving change in the way healthcare can and will be provided, and remote monitoring is one aspect of the mHealth industry that can cut costs and improve care,” says Stephanie Lawrence, Research Analyst at ABI Research. “New home and remote patient monitoring smart footwear devices grant healthcare providers 24/7 access to in-depth, real-time health updates concerning their patients’ posture and gait. Such detailed reporting used to be constricted to a hospital bed; now healthcare providers can paint a fuller picture of their patient’s health outside of the hospital, ultimately allowing them to better monitor ongoing issues and make more accurate diagnoses.”

Home monitoring device and system providers target a wide age demographic, from babies and children to the elderly. The Owlet Smart Sock, for instance, features pulse oximetry technology and monitors the heart rate and oxygen levels of an infant to reduce the chances of a fatality. Other devices, such as GTX Corp’s GPS SmartSole, consist of insoles that use GPS and cellular connectivity, ideal for tracking an elderly person’s location and capable of sending alerts to caregivers if the patient wanders off.

For remote patient monitoring, companies are already turning to smart footwear as a form factor to support diagnostic medical data collection. This includes companies like Plantiga, FeetMe, and Orpyx. For instance, diabetic patients are at risk for peripheral neuropathy, or sensory loss, and often cannot detect dangerous pressure levels in their bodies. Orpyx’s SurroSense RX has insoles that use sensors to detect the amount of pressure that a person places on each part of the foot. The device can then alert the user and his/her doctor to any issues.

“In order to gain adequate market share, rising vendors in the smart footwear market need to develop devices that can detect exactly how a person is walking, and provide accurate feedback concerning any issues,” concludes Lawrence. “This will ensure that healthcare workers receive detailed health information about their patients, and will allow the smart footwear market to continue to advance and grow significantly.”

The findings are from ABI Research’s Smart Footwear Technologies and Applications report.

About ABI Research

ABI Research is a global technology intelligence firm uniquely positioned at the intersection of technology solution providers and end-market companies. We serve as the bridge that seamlessly connects these two segments by providing exclusive research and expert guidance to drive successful technology implementations and deliver strategies proven to attract and retain customers.

ABI Research 是一家全球性的技术情报公司,拥有得天独厚的优势,充当终端市场公司和技术解决方案提供商之间的桥梁,通过提供独家研究和专业性指导,推动成功的技术实施和提供经证明可吸引和留住客户的战略,无缝连接这两大主体。

For more information about ABI Research’s services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific, or visit

Contact ABI Research

Media Contacts

Americas: +1.516.624.2542
Europe: +44.(0).203.326.0142
Asia: +65 6950.5670

Related Service